Cargando…
Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive
BACKGROUND: Acidform gel, an acid-buffering product that inactivates spermatozoa, may be an effective topical non-hormonal contraceptive. This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretio...
Autores principales: | Keller, Marla J., Carpenter, Colleen A., Lo, Yungtai, Einstein, Mark H., Liu, Congzhou, Fredricks, David N., Herold, Betsy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466198/ https://www.ncbi.nlm.nih.gov/pubmed/23056520 http://dx.doi.org/10.1371/journal.pone.0046901 |
Ejemplares similares
-
Altered Biomarkers of Mucosal Immunity and Reduced Vaginal Lactobacillus Concentrations in Sexually Active Female Adolescents
por: Madan, Rebecca Pellett, et al.
Publicado: (2012) -
Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012) -
Lactobacillus crispatus Dominant Vaginal Microbiome Is Associated with Inhibitory Activity of Female Genital Tract Secretions against Escherichia coli
por: Ghartey, Jeny P., et al.
Publicado: (2014) -
Vaginal bacteria elicit acute inflammatory response in fallopian tube organoids: a model for pelvic inflammatory disease
por: Yu, Bo, et al.
Publicado: (2023) -
Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis
por: Srinivasan, Sujatha, et al.
Publicado: (2010)